Tag - AOBiome

AOBiome Announces First-of-its Kind Trial of Live Topical Bacterial Treatment for Acne

Leading skin microbiome company AOBiome announced today the launch of its Phase 2B trial using its first-in-class live bacteria to treat acne. Phase 2B marks the advancement from the company’s successful Phase 1B/2A dose-ranging safety study, which resulted in no serious adverse events and no difference in adverse events between treatment and vehicle groups. Read more >>